Clinical Trial Update: A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for relapsed and relapsed/refractory multiple myeloma patients, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma, Deletion 17P Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING